Monofer Dosing Frequency
Monofer (iron isomaltoside/ferric derisomaltose) should be administered as a single dose and repeated only when iron deficiency anemia reoccurs. 1
Specific Dosing Protocol
According to the FDA-approved prescribing information, the dosing schedule is straightforward:
- For patients ≥50 kg: 1,000 mg as a single IV infusion over at least 20 minutes 1
- For patients <50 kg: 20 mg/kg actual body weight as a single IV infusion over at least 20 minutes 1
- Repeat dosing: Only when iron deficiency anemia reoccurs 1
Key Clinical Considerations
There is no predetermined schedule for repeat dosing. The decision to re-administer Monofer should be based on:
- Monitoring hemoglobin and hematocrit response
- Tracking iron parameters (serum ferritin and transferrin saturation)
- Clinical reassessment for recurrent IDA 1
The FDA label explicitly warns against administering Monofer to patients with iron overload, emphasizing the importance of monitoring iron parameters during therapy 1. This reinforces that repeat dosing should be guided by laboratory evidence of recurrent deficiency rather than a fixed schedule.
Monitoring After Treatment
Guidelines suggest reasonable monitoring intervals after IV iron repletion 2:
- Check hemoglobin every 4 weeks until normalized
- Once hemoglobin normalizes, check blood counts every 3 months for 12 months
- Then 6-monthly monitoring for 2-3 years 2
This monitoring framework helps identify when IDA has truly reoccurred and repeat dosing is warranted.
Important Safety Caveat
Monofer must only be administered where personnel and therapies for treating serious hypersensitivity reactions are immediately available, and patients require monitoring for at least 30 minutes after infusion completion 1. The incidence of serious hypersensitivity reactions was 0.3% in clinical trials 1.